These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 989559)

  • 1. Influenza vaccination in patients with multiple sclerosis.
    Sibley WA; Bamford CR; Laguna JF
    JAMA; 1976 Oct; 236(17):1965-6. PubMed ID: 989559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis.
    De Keyser J; Zwanikken C; Boon M
    J Neurol Sci; 1998 Jul; 159(1):51-3. PubMed ID: 9700703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccination in multiple sclerosis.
    Sibley WA; Bamford CR; Laguna JF
    JAMA; 1976 Oct; 236(17):1935. PubMed ID: 989548
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group.
    Confavreux C; Suissa S; Saddier P; Bourdès V; Vukusic S;
    N Engl J Med; 2001 Feb; 344(5):319-26. PubMed ID: 11172162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophoretic study of the cerebrospinal fluid proteins of a patient with multiple sclerosis and recurrent meningitis (with rhinorrhea).
    Verheecke P; Crevits L; Thiery E; Eecken HV
    Acta Neurol Belg; 1977; 77(1):51-7. PubMed ID: 842278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal and H1N1v influenza vaccines in MS: safety and compliance.
    Auriel E; Gadoth A; Regev K; Karni A
    J Neurol Sci; 2012 Mar; 314(1-2):102-3. PubMed ID: 22056469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swine-influenza vaccination in multiple sclerosis.
    Myers LW; Ellison GW; Lucia M; Novom S
    N Engl J Med; 1976 Nov; 295(21):1204. PubMed ID: 790182
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B.
    Merelli E; Casoni F
    Neurol Sci; 2000; 21(4 Suppl 2):S853-6. PubMed ID: 11205362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
    Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
    Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly.
    Honkanen PO; Keistinen T; Kivelä SL
    Arch Intern Med; 1996 Jan; 156(2):205-8. PubMed ID: 8546555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis after allergen-specific immunotherapy and influenza vaccination.
    Nakajima H; Ohtsuka S; Nishina T; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
    Eur Neurol; 2003; 50(4):248-9. PubMed ID: 14634270
    [No Abstract]   [Full Text] [Related]  

  • 13. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
    Vrethem M; Malmgren K; Lindh J
    J Neurol Sci; 2012 Oct; 321(1-2):89-91. PubMed ID: 22841884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.
    Tambyah PA; Wilder-Smith A; Pavlova BG; Barrett PN; Oh HM; Hui DS; Yuen KY; Fritsch S; Aichinger G; Loew-Baselli A; van der Velden M; Maritsch F; Kistner O; Ehrlich HJ
    Vaccine; 2012 Jan; 30(2):329-35. PubMed ID: 22080174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study.
    Farez MF; Ysrraelit MC; Fiol M; Correale J
    Mult Scler; 2012 Feb; 18(2):254-6. PubMed ID: 21828198
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
    Shoenfeld Y; Aron-Maor A
    J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies.
    Pellegrino P; Carnovale C; Perrone V; Pozzi M; Antoniazzi S; Radice S; Clementi E
    Vaccine; 2014 Aug; 32(37):4730-5. PubMed ID: 25000592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytology of the cerebrospinal fluid in multiple sclerosis].
    Dufresne JJ
    Rev Otoneuroophtalmol; 1969 Nov; 41(7):359-65. PubMed ID: 5403003
    [No Abstract]   [Full Text] [Related]  

  • 20. Swine flu vaccine adjuvants and multiple sclerosis - Is there potential for harmful effect?
    Oztürk S
    Med Hypotheses; 2010 Jul; 75(1):50-2. PubMed ID: 20171793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.